Skip to content

The Archive · A Source

The Impact of Introducing Successive Biosimilars on Changes in Prices of Adalimumab, Infliximab, and Trastuzumab — Polish Experiences

PMC 2021 pmc.ncbi.nlm.nih.gov/articles/PMC8297232